Dr. Florian von Baum
Rechtsanwalt, Partner, Sector Head Technology, Science & Industry
Our global team of advisers support TMT and IP-rich industries around the world being redefined by digital transformation, including Diversified Industrials, Healthcare, Life Sciences and Technology & Digital Markets.
Dr. Florian von Baum, Head of our Technology, Science & Industry sector, discusses the challenges and opportunities for organisations in the sector.
Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.
Partner, Head of Diversified Industrial
Nicole advises both listed and unlisted companies on all aspects of domestic and cross-border M&A transactions and joint ventures.
Partner, Head of IP & Life sciences
Clare leads Pinsent Masons’ IP and Life Sciences teams.
Partner, Head of Healthcare
Joanne is head of the Health sector but sits within the Corporate Group, specialising principally in private company and private equity work including acquisitions and disposals, buy-in and buy-outs, joint ventures and investments.
Our expertise, at your disposal
With over 430 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).